Summit Financial’s Sanofi SNY Stock Holding History

Summit Financial’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	+5,447	New	+$243K	﹤0.01%	1453

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Summit Financial's SNY Position: Q2 2026 in Review

Summit Financial opened a new position in Sanofi (SNY) in Q2 2026: 5,447 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #1453 among its holdings.

714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Summit Financial held 5,447 shares of Sanofi worth $232K as of Q2 2026.
Sanofi was a new Summit Financial position in Q2 2026.
Sanofi made up ﹤0.01% of Summit Financial's portfolio in Q2 2026, its #1453 holding.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.